SF3A1 and colorectal carcinoma: Blood plasma cell-free DNA sequencing revealed major clonal mutations of SF3a1 and others were found in all samples from one advanced CRC patient who showed rapid but not sustained response to chemotherapy, implying SF3a1 might contribute to chemotherapy resistance and the pathogenesis of CRC 35.